Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study
| Image |  |
|---|---|
| Description | scientific article published on 20 October 2018 |
| Author/s |
author: Susan O'Brien Steven M Horwitz |
| Publication date | October 20, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |